V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007799 | 240004818 | 0 | 67 | Not known (9) | 2017-05-14 | 2017-06-02 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240034683 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007800 | 240013555 | 1.73 | 72.5 | null | 2017-09-06 | 2017-09-08 | DA 3 + 10 | N | N | 240034688 | DA |
| 240007801 | 240004819 | 1.61 | 66.2 | Palliative (P) | null | 2013-05-21 | BENDAMUSTINE | N | null | 240034689 | BENDAMUSTINE |
| 240007802 | 240004820 | 1.59 | 93 | Curative (C) | 2017-01-17 | 2017-01-25 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 240034690 | NOT MATCHED |
| 240007803 | 240010673 | 1.67 | 70 | Disease modification (D) | 2013-03-18 | 2013-03-18 | Chlorambucil | 02 | N | 240034699 | CHLORAMBUCIL |
| 240007804 | 240004821 | 1.5 | 50.5 | Curative (C) | 2016-07-29 | 2016-08-06 | DA 3 + 10 | 01 | Y | 240034700 | DA |
| 240007805 | 240010674 | 1.62 | 119.2 | Palliative (P) | null | 2015-08-03 | Chlorambucil | N | N | 240034701 | CHLORAMBUCIL |
| 240007806 | 240013556 | 1.63 | 81.9 | Curative (C) | 2015-11-21 | 2015-11-24 | Bendamustine + prednisolone | 02 | null | 240034702 | BENDAMUSTINE |
| 240007807 | 240004822 | 0 | 70.3 | Palliative (P) | 2015-08-27 | 2015-09-19 | Chlorambucil | N | N | 240034708 | CHLORAMBUCIL |
| 240007808 | 240010675 | 1.5 | 100.3 | Curative (C) | 2014-03-06 | 2014-03-13 | Carboplatin + Etoposide iv&po | N | N | 240034711 | CARBOPLATIN + ETOPOSIDE |
| 240007809 | 240004823 | 1.74 | 76.4 | Palliative (P) | 2013-10-18 | 2014-03-14 | ALCL ALCL 99 Closed Pre Phase | Y | N | 240034713 | NOT MATCHED |
| 240007810 | 240010676 | 1.52 | 89.7 | Curative (C) | 2016-04-13 | 2016-04-20 | DA 3 + 10 | 02 | N | 240034715 | DA |
| 240007811 | 240004824 | 1.73 | 68.6 | Curative (C) | 2017-06-30 | 2017-07-06 | Carboplatin + Etoposide IV 3 day | N | N | 240034717 | CARBOPLATIN + ETOPOSIDE |
| 240007812 | 240010677 | 1.6 | 67.2 | Disease modification (D) | 2015-04-10 | 2015-04-17 | BENDAMUSTINE | 2 | N | 240034726 | BENDAMUSTINE |
| 240007813 | 240010677 | null | null | Palliative (P) | 2016-07-18 | 2016-08-11 | Carboplatin AUC 6 - 10 | null | null | 240034726 | CARBOPLATIN |
| 240007814 | 240010677 | null | 101.5 | Palliative (P) | 2015-06-23 | 2015-07-07 | Carboplatin AUC 6 - 10 | N | N | 240034726 | CARBOPLATIN |
| 240007815 | 240010677 | 1.68 | null | Curative (C) | null | 2017-12-17 | null | null | null | 240034726 | NOT MATCHED |
| 240007816 | 240004825 | 1.75 | 80.6 | Curative (C) | 2015-12-31 | 2015-12-31 | Trial Unspecified | N | N | 240034744 | TRIAL |
| 240007817 | 240010678 | 1.65 | 92.9 | null | 2013-12-21 | 2014-01-18 | Carboplatin AUC 2 - 5 | N | N | 240034747 | CARBOPLATIN |
| 240007818 | 240004826 | 1.7 | null | Curative (C) | 2016-09-07 | 2016-09-14 | Trial Unspecified | N | N | 240034752 | TRIAL |
| 240007819 | 240004826 | 1.55 | null | Palliative (P) | 2014-06-01 | 2014-06-01 | Hydroxycarbamide | N | N | 240034752 | HYDROXYCARBAMIDE |
| 240007820 | 240004827 | 1.68 | 90 | Curative (C) | null | 2018-01-02 | CYTARABINE + DAUNORUBICIN | 2 | N | 240034755 | DA |
| 240007821 | 240004828 | null | 77.5 | Curative (C) | 2014-12-07 | 2014-12-25 | Carboplatin AUC 6 - 10 | N | N | 240034756 | CARBOPLATIN |
| 240007822 | 240010680 | null | 41.2 | Palliative (P) | 2015-04-25 | 2015-04-25 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 240034757 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007823 | 240010680 | 1.84 | 0 | Curative (C) | 2016-10-25 | 2016-10-25 | ALCL ALCL 99 Closed Pre Phase | 2 | N | 240034757 | NOT MATCHED |
| 240007824 | 240010680 | 1.72 | 60 | Palliative (P) | 2016-11-25 | 2016-12-04 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240034757 | CHLORAMBUCIL + RITUXIMAB |
| 240007825 | 240004829 | 1.61 | null | Palliative (P) | 2014-08-18 | 2014-09-02 | Bevacizumab+Carbo+Pacliaxel | null | null | 240034760 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007826 | 240004830 | 1.6 | 102.9 | Palliative (P) | 2014-11-19 | 2014-11-20 | Hydroxycarbamide | N | N | 240034766 | HYDROXYCARBAMIDE |
| 240007827 | 240004830 | 1.79 | 52.4 | Palliative (P) | 2013-08-22 | 2013-08-22 | Chlorambucil | 1 | N | 240034766 | CHLORAMBUCIL |
| 240007828 | 240004831 | 1.6 | 53.7 | null | 2016-03-22 | 2016-03-24 | R Chlorambucil | N | N | 240034770 | CHLORAMBUCIL + RITUXIMAB |
| 240007829 | 240004831 | 1.79 | 67.6 | Palliative (P) | 2015-09-04 | 2015-09-16 | Chlorambucil | N | N | 240034770 | CHLORAMBUCIL |
| 240007830 | 240013559 | 1.52 | 32.2 | Palliative (P) | 2016-05-19 | 2016-05-20 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034773 | CHLORAMBUCIL + RITUXIMAB |
| 240007831 | 240013559 | 1.72 | 78.6 | Disease modification (D) | 2015-10-14 | 2015-10-14 | Trial Unspecified | Y | N | 240034773 | TRIAL |
| 240007832 | 240004832 | 1.77 | 77.2 | null | 2013-11-20 | 2013-11-20 | Carboplatin + Etoposide iv&po | N | N | 240034777 | CARBOPLATIN + ETOPOSIDE |
| 240007833 | 240010683 | 1.75 | 102 | Palliative (P) | 2014-03-24 | 2014-04-22 | CARBOPLATIN | N | Y | 240034778 | CARBOPLATIN |
| 240007834 | 240004833 | 1.69 | 56 | Curative (C) | 2017-01-18 | 2017-02-12 | INTERLACE TRIAL | 2 | N | 240034784 | INTERLACE TRIAL |
| 240007835 | 240010684 | 1.74 | null | Curative (C) | 2013-05-08 | 2013-05-30 | ALCL ALCL 99 Closed Pre Phase | 1 | null | 240034787 | NOT MATCHED |
| 240007836 | 240004834 | 1.6 | 78 | Palliative (P) | 2015-03-06 | 2015-03-25 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240034789 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007837 | 240004835 | 1.73 | 81.7 | Adjuvant (A) | 2013-07-24 | 2013-07-26 | Carboplatin AUC 6 - 10 | N | N | 240034790 | CARBOPLATIN |
| 240007838 | 240004835 | 1.85 | 80.6 | Palliative (P) | 2015-12-23 | 2015-12-23 | Chlorambucil + Pred + Rituximab | 2 | N | 240034790 | CHLORAMBUCIL + RITUXIMAB |
| 240007839 | 240004835 | 1.8 | 68.8 | Disease modification (D) | 2015-03-10 | 2015-03-23 | Bendamustine + prednisolone | 02 | N | 240034790 | BENDAMUSTINE |
| 240007840 | 240004836 | 0 | 105 | Curative (C) | 2018-07-06 | 2018-07-20 | CHLORAMBUCIL + RITUXIMAB | 01 | N | 240034799 | CHLORAMBUCIL + RITUXIMAB |
| 240007841 | 240004837 | null | 78 | Curative (C) | null | 2017-10-17 | Trial Unspecified | N | N | 240034801 | TRIAL |
| 240007843 | 240004839 | 1.62 | 40 | Curative (C) | 2013-12-24 | 2013-12-24 | R Chlorambucil | Y | Y | 240034807 | CHLORAMBUCIL + RITUXIMAB |
| 240007844 | 240004839 | null | 31.7 | Curative (C) | 2016-07-11 | 2016-07-12 | Trial Unspecified | N | N | 240034807 | TRIAL |
| 240007845 | 240004840 | 1.75 | 101.5 | Palliative (P) | 2014-02-26 | 2014-03-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | N | 240034817 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007846 | 240004840 | null | 83.7 | Palliative (P) | 2015-11-17 | 2015-11-21 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240034817 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007847 | 240004841 | 1.85 | null | Palliative (P) | 2015-05-01 | 2015-05-06 | R Chlorambucil | null | N | 240034827 | CHLORAMBUCIL + RITUXIMAB |
| 240007848 | 240004842 | null | 64.2 | Adjuvant (A) | 2017-12-27 | 2017-12-28 | Bevacizumab+Carbo+Pacliaxel | N | N | 240034831 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007849 | 240010688 | 0 | 65.3 | Not known (9) | 2018-01-11 | 2018-01-17 | INTERLACE TRIAL | N | N | 240034832 | INTERLACE TRIAL |